| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/16/2013 | EP2649050A1 Compounds |
| 10/16/2013 | EP2649048A1 Multifunctional nitroxide derivatives and uses thereof |
| 10/16/2013 | EP2649035A1 A complex of garcinol, cyclodextrin and method thereof |
| 10/16/2013 | EP2648741A1 Cardio-protective agents from kiwifruits |
| 10/16/2013 | EP2648730A2 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof |
| 10/16/2013 | EP2648727A2 Compositions and methods for mobilizing stem cells |
| 10/16/2013 | EP2648724A1 Hydroxylated aminotriazole derivatives as alx receptor agonists |
| 10/16/2013 | EP2648698A1 Liposomal formulation of dalcetrapib |
| 10/16/2013 | CN103354749A Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof |
| 10/16/2013 | CN103354745A Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof |
| 10/16/2013 | CN103354742A Novel oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 10/16/2013 | CN103352037A Aptamer therapeutics useful in the treatment of complement-related disorders |
| 10/16/2013 | CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit |
| 10/16/2013 | CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof |
| 10/16/2013 | CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 10/16/2013 | CN103349779A Healthcare soft capsule containing elements, vitamins and vegetable polyketide synthase and used for controlling cardiovascular and cerebrovascular diseases |
| 10/16/2013 | CN103349742A Monkshood cornus traditional Chinese medicine electuary |
| 10/16/2013 | CN103349739A Blood-pressure-lowering health-care oral liquid and preparation method thereof |
| 10/16/2013 | CN103349737A Traditional Chinese medicine composite for treating headache and preparation method of traditional Chinese medicine composite |
| 10/16/2013 | CN103349735A Traditional Chinese medicine for treating hypertension |
| 10/16/2013 | CN103349729A Traditional Chinese medicine comprising radix paeoniae rubra and preparation method thereof |
| 10/16/2013 | CN103349727A Xinnaoan |
| 10/16/2013 | CN103349722A Medicine for treating frequent ventricular premature beat |
| 10/16/2013 | CN103349721A Medicine for treating hemiplegia and preparation method of medicine |
| 10/16/2013 | CN103349700A Medicine for treating haemorrhoids and preparation method of medicine |
| 10/16/2013 | CN103349685A Traditional Chinese medicine comprising radix paeoniae rubra and preparation method thereof |
| 10/16/2013 | CN103349671A Resveratrol and spirulina composition and preparations and preparation method thereof |
| 10/16/2013 | CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof |
| 10/16/2013 | CN103349656A Valsartan capsule and preparation method thereof |
| 10/16/2013 | CN102885973B Chinese medicinal decoction for treating hypertension |
| 10/16/2013 | CN102813837B Preparation method of traditional Chinese medicine for treating blood pressure rising type acute glomerulonephritis |
| 10/16/2013 | CN102813814B Traditional Chinese medicine formula for treating hypotension |
| 10/16/2013 | CN102784274B Medicine for treating and nursing diabetic feet |
| 10/16/2013 | CN102755599B Chinese medicine for treating yin deficiency, exogenous pathogens and thoracic obstruction in chest |
| 10/16/2013 | CN102698135B Traditional Chinese medicine composition for treating hypertension, hyperglycemia and hyperlipidemia, and application thereof |
| 10/16/2013 | CN102688184B Preparation method of ephedrine hydrochloride injection for improving rat blood rheological obstacle |
| 10/16/2013 | CN102670670B Preparation method of ginkgo dipyridolum injection with high content of ginkgo terpene lactones |
| 10/16/2013 | CN102614308B Method for extracting bioactivator in hot chili residue through subcritical water |
| 10/16/2013 | CN102614224B Novel medical application of propolis total flavonoid |
| 10/16/2013 | CN102614149B Method for preparing sinomenine capsules |
| 10/16/2013 | CN102600435B Device and formula of traditional Chinese medicine for stabilizing heart and relieving asthma |
| 10/16/2013 | CN102552841B Traditional Chinese medicine for treating apoplexy sequelae |
| 10/16/2013 | CN102552727B Medicinal composition for treating hemorrhoids |
| 10/16/2013 | CN102488764B Preparation method for total saponins of Rubus parviflolius |
| 10/16/2013 | CN102488739B Folk recipe foot bath composition |
| 10/16/2013 | CN102470121B Pharmaceutical compositions comprising dronedarone |
| 10/16/2013 | CN102432760B Quaternary amine konjac glucomannan adduct, its preparation method and application |
| 10/16/2013 | CN102416107B Medicament for treating cerebral vascular disease |
| 10/16/2013 | CN102250099B Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
| 10/16/2013 | CN102151253B Nifedipine osmotic pump type controlled release tablet |
| 10/16/2013 | CN102138888B Alprostadil lipid nanosphere gel and preparation method thereof |
| 10/16/2013 | CN102114012B Medicinal composition for treating heart cerebrovascular diseases as well as preparation method and application thereof |
| 10/16/2013 | CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 10/16/2013 | CN102083799B Benzimidazole derivatives used as FXR agonists |
| 10/16/2013 | CN102030709B Benzazepines compounds serving as vasopressin receptor antagonism |
| 10/16/2013 | CN101952249B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 10/16/2013 | CN101873866B Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 10/16/2013 | CN101822652B Vinpocetine transdermal patch and preparation method thereof |
| 10/16/2013 | CN101810862B Tanshinone IIA oral administration polymer micelle composition |
| 10/16/2013 | CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis |
| 10/16/2013 | CN101744988B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
| 10/16/2013 | CN101605905B Method for glycosylation of flavonoid |
| 10/16/2013 | CN101506203B 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other syndromes |
| 10/16/2013 | CN101489577B Method and compound for the treatment of valvular disease |
| 10/15/2013 | US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 10/15/2013 | US8557993 Crystalline forms of pitavastatin calcium |
| 10/15/2013 | US8557962 Treatment of endothelial dysfunction in diabetic patients |
| 10/15/2013 | US8557796 Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods |
| 10/15/2013 | US8557785 In vivo production of small interfering RNAS that mediate gene silencing |
| 10/15/2013 | US8557280 Stable pharmaceutical composition and methods of using same |
| 10/15/2013 | US8557240 Method for the treatment of inflammatory disorders |
| 10/15/2013 | CA2728997C Pharmaceutical composition of levamlodipine or pharmaceutically acceptable salt thereof and .beta. receptor blocking agent, and use thereof |
| 10/15/2013 | CA2615663C Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 10/15/2013 | CA2534869C A pharmaceutical composition comprising an extract from trichilia sp. and its use for treating and preventing ventricular fibrillation |
| 10/15/2013 | CA2487732C Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders |
| 10/15/2013 | CA2410762C Feline hepatocyte growth factor |
| 10/10/2013 | WO2013152076A1 Compositions and methods for treating hypertension |
| 10/10/2013 | WO2013151923A1 Pyrimidinone carboxamides as inhibitors of endothelial lipase |
| 10/10/2013 | WO2013151682A1 Process for forming microbubbles with high oxygen content and uses thereof |
| 10/10/2013 | WO2013150303A1 Stem cell microparticles |
| 10/10/2013 | WO2013150173A1 New alpha2 adrenoceptor agonists |
| 10/10/2013 | WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors |
| 10/10/2013 | WO2013104598A3 Substituted, annulated imidazoles and pyrazoles, and use thereof |
| 10/10/2013 | US20130267477 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia |
| 10/10/2013 | US20130266553 Albumin Fusion Proteins |
| 10/09/2013 | EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound |
| 10/09/2013 | EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors |
| 10/09/2013 | EP2647385A1 Tie2 ACTIVATOR, VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, ANTI-ANGIOGENIC AGENT, AGENT FOR MATURING BLOOD VESSELS, AGENT FOR NORMALIZING BLOOD VESSELS, AGENT FOR STABILIZING BLOOD VESSELS, AND PHARMACEUTICAL COMPOSITION |
| 10/09/2013 | EP2647381A1 Orally disintegrating tablet |
| 10/09/2013 | EP2646555A1 Methods and pharmaceutical compositions for the treatment of heart failure |
| 10/09/2013 | EP2646471A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody |
| 10/09/2013 | EP2646444A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes |
| 10/09/2013 | EP2646427A1 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases |
| 10/09/2013 | EP2646421A1 7-nitro-5-phenyl-1-(pyrrolidin-1-ylmethyl)-1h-benzo[e][1,4]diazepin-2(3h)-one and other benzodiazepine derivatives |
| 10/09/2013 | EP2646415A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646114A1 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646028A1 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646027A1 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646026A1 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646024A1 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |